AMGN
AMGEN INC
NASDAQ · Healthcare · Drug Manufacturers - General · US
$433.14
−0.21%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$437.89
From 52W high−2.47%
Volume1.08M
Market cap$234.17B
P/E (TTM)26.7x
P/S (TTM)6.1x
Div yield2.29%
Key dataOct 16, 2026
Open
$437.89
From 52W high
−2.47%
Volume
1.08M
Market cap
$234.17B
ValuationView details →
P/E (Fwd)
17.9x
EV/EBITDA
15.7x
P/E (TTM)
26.7x
RSI (14)
64.4
MomentumView details →
1D Return
−0.21%
YTD Return
+33.18%
SummaryUpdated Jun 1, 2026
Amgen Inc. (NASDAQ:AMGN) is one of the world's largest independent biotechnology companies, founded in 1980 and headquartered in Thousand Oaks, California. The company went public in 1983 and has grown to become a leading developer and manufacturer of human therapeutics focused on serious illnesses. Amgen operates globally, serving healthcare providers including physicians, dialysis centers, hospitals, and pharmacies through pharmaceutical wholesale distributors and direct channels. The company has built its reputation on innovative biotechnology medicines, particularly in areas where few treatment options previously existed.
Similar companies
Latest newsMore news →
AMGEN INC shares closed at $434.03, up 1.86% from the previous close.19h agoAMGEN INC shares rose 2.6% to $413.08 during the recent trading day.9d agoSPJIMR reported that all 365 participants in its Class of 2028 secured summer internships, with a median monthly stipend of ₹2 lakhs, an average of ₹1.86 lakhs and a highest stipend of ₹3 lakhs.9d ago